Key Points
- APUS Chloe 50K appears in U.S. online retail channels.
- Rated for up to 50,000 puffs with 20ml of e-liquid.
- Features a purse-inspired body and chain attachment.
- Uses a 1,250mAh battery, 0.6Ω dual mesh coil and status indicators.
- The product does not appear on the FDA’s authorized e-cigarette list.
2Firsts
July 15, 2026
APUS Chloe 50K has appeared across U.S.-facing online retail platforms, including Element Vape, Vapesourcing and other wholesale and retail channels. While many high-puff disposables compete through industrial styling, screen size or operating modes, the Chloe 50K uses a miniature purse-inspired body and chain attachment to add a fashion-oriented identity to its 50,000-puff positioning.
APUS lists the device with a 20ml prefilled e-liquid capacity, 5% nicotine strength, a 1,250mAh rechargeable battery, Type-C charging and 15 flavor options. Vaping360 lists the product’s release date as May 2026.
Purse-Inspired Styling Drives Product Differentiation
The defining feature of the Chloe 50K is its exterior design. Product images and retail listings show a purse-like body with a chain attachment that can function as a decorative element or be connected to a bag. Compared with the rectangular and cylindrical forms commonly used in disposable vapes, the design adopts visual cues associated with fashion accessories.
APUS describes the concept as “Moving Style” and highlights a body that changes appearance across different operating states. The official page also mentions two modes, although detailed output specifications for each mode are not disclosed.
50,000-Puff Claim Meets Device-Status Visibility
The Chloe 50K is rated for up to 50,000 puffs and comes prefilled with 20ml of e-liquid. It uses a 0.6Ω dual mesh coil and a 1,250mAh rechargeable battery with Type-C charging. Battery and e-liquid indicators provide real-time visibility into basic device status.
The draw-activated product is offered in 15 flavors, with U.S. retail listings generally showing a 5% nicotine configuration. One U.S. wholesale listing prices the product at approximately US$15.75, while a preorder promotion listed it at about US$16.39. Actual retail pricing may vary by channel and promotion.
Parameter | Information |
Brand | APUS |
Product Name | Chloe 50K |
Product Type | Rechargeable disposable vape |
Product Design | Purse-inspired body with chain attachment |
Puff Count | Up to 50,000 puffs |
E-Liquid Capacity | 20ml |
Nicotine Strength | 5% |
Coil | 0.6Ω dual mesh coil |
Battery | 1,250mAh rechargeable battery |
Charging | USB Type-C |
Operating Modes | Two modes; detailed output specifications not disclosed |
Display | Battery and e-liquid indicators |
Activation | Draw activated |
Flavor Options | 15 |
Public Release | May 2026 |
Market | U.S. online retail market |
Reference Price | Approximately US$15.75–US$16.39, depending on channel and promotion |
FDA Status | Not listed among FDA-authorized e-cigarettes; no public MGO identified |
Product Appears Across U.S. Online Retail Channels
The Chloe 50K is listed through Element Vape, Vapesourcing and other U.S.-facing online retail and wholesale channels. Its U.S. positioning combines high puff count, fashion-oriented design and device-status visualization.
However, current public information comes mainly from the brand’s website and retail listings. APUS has not been identified as issuing a separate U.S.-specific launch announcement. It is therefore more accurate to describe the product as having entered U.S. online retail channels rather than as having received an official U.S. market launch.
U.S. Regulatory Status
As of publication, the FDA lists 45 authorized e-cigarette products, and neither APUS nor Chloe 50K appears on that list. The agency states that the listed products are the only authorized e-cigarettes that may currently be lawfully sold in the United States. New tobacco products generally require a written FDA marketing order before they may be legally introduced into interstate commerce.
The Chloe 50K’s availability through U.S. online retail channels therefore does not indicate that it has received a Marketing Granted Order under the PMTA pathway. 2Firsts has not identified publicly available FDA records showing an MGO for the product.
Industry Perspective
Product differentiation in the U.S. high-puff disposable segment is expanding beyond puff count, e-liquid capacity and screen functions toward exterior design and consumer-group positioning. Through its purse-like form, chain attachment and status indicators, the Chloe 50K presents a disposable vape as a fashion-oriented consumer product.
At the same time, retail availability and regulatory authorization remain separate issues in the United States. For products absent from the FDA’s authorized list, design innovation and channel presence do not remove regulatory uncertainty. The Chloe 50K therefore illustrates both the fashion-driven evolution of high-puff disposables and the continuing tension between rapid product development and U.S. market authorization requirements.
Product Specifications
Follow 2Firsts for the latest news on global tobacco and next-generation nicotine product launches, product innovation, technology evolution, and market trends.
Cover image source: APUS official website
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
